Ardelyx | ARDX - Cost Of Sales

Stock Price
6.37
Daily Change
-0.27 -4.00%
Monthly
-19.02%
Yearly
18.75%
Q1 Forecast
5.55

Ardelyx reported $3.98M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Abbott USD 4.92B 535M Dec/2025
Amgen USD 1.79B 128M Dec/2025
Ardelyx USD 3.98M 10.84M Sep/2025
aTyr Pharma USD 22.13M 6.75M Sep/2025
Corcept Therapeutics USD 2.54M 2.05M Dec/2025
Curis USD 10.27M 610K Jun/2024
Sanofi EUR 3.76B 344M Dec/2025
TG Therapeutics USD 38.14M 10.05M Dec/2025
United Therapeutics USD 474.7M 373.8M Dec/2025
Xoma 116K 112.7K Jun/2024